These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3287800)

  • 41. Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer.
    van Poppel H; Billen J; Goethuys H; Elgamal AA; Gerits M; Mortelmans L; Blanckaert N; Baert L
    Anticancer Res; 1996; 16(4B):2205-7. PubMed ID: 8694544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How to integrate serum tumor markers into clinical oncologic practice.
    van Dalen A
    Nutrition; 1995; 11(5 Suppl):489-91. PubMed ID: 8748205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tumor markers used in oncology].
    Arce Vela R
    Rev Gastroenterol Peru; 1989; 9(2):100-5. PubMed ID: 2519234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening, diagnosis, and monitoring of gynecologic malignancies.
    Montz FJ; Berek JS
    Curr Opin Oncol; 1989 Oct; 1(1):75-81. PubMed ID: 2489952
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of human serum based tumor marker control.
    Chapman D; Fontana L
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):114-7. PubMed ID: 2593008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative immunoenzyme analysis of the fertility alpha2-microglobulin in healthy donors and in patients with gynecological malignancies].
    Shcherbakova LA; Tatarinov IuS; Kalashnikov VV; Murashov VA; Olefirenko GO
    Vopr Med Khim; 1988; 34(5):23-5. PubMed ID: 2464236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Basic and clinical study of oncofetal antigen in the field of gynecology].
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Aug; 39(8):1204-46. PubMed ID: 3451933
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of tumor markers in patients with solid cancers: A critical review.
    Duffy MJ
    Eur J Intern Med; 2007 May; 18(3):175-84. PubMed ID: 17449388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Appropriate requesting of serum tumour markers.
    Kilpatrick ES; Lind MJ
    BMJ; 2009 Sep; 339():b3111. PubMed ID: 19773324
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention and early detection of cancer.
    Berchuck A; Einstein MH
    Gynecol Oncol; 2011 Apr; 121(1):1. PubMed ID: 21419284
    [No Abstract]   [Full Text] [Related]  

  • 52. The Dilemma of Serum Tumor Marker (STM) Flares.
    Venniyoor A; Al Bahrani B; Rajan B
    Gulf J Oncolog; 2014 Jan; 1(15):63-7. PubMed ID: 24610290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor markers in diagnostic pathology.
    Clin Lab Med; 1990 Mar; 10(1):1-250. PubMed ID: 2331845
    [No Abstract]   [Full Text] [Related]  

  • 54. [Definition and classification of tumor marker].
    Ishii M
    Nihon Rinsho; 1996 Jun; 54(6):1473-8. PubMed ID: 8691595
    [No Abstract]   [Full Text] [Related]  

  • 55. [Tumor markers in gynecology. General review].
    Briese V; Strache RR
    Zentralbl Gynakol; 1988; 110(5):257-66. PubMed ID: 3287800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tumor markers in gynecological and breast cancer].
    Jobo T; Sato R; Kuramoto H
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical use of gynaecologic tumour markers.
    Halila H; Alfthan H; Stenman UH
    Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.